SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention as its Phase 3 REGAL AML trial approaches the final efficacy trigger, with the event count reported at 78 of 80 and healthcare-industry executives describing GPS as potentially transformative. Traders remain divided: bullish participants view the prolonged event timeline and CEO commentary as encouraging, while bearish voices question the trials statistical power, dosing changes, and the lack of official confirmation of the 80th event.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops preliminary Q2 update and amended convertible-note exchange are driving attention, with traders focusing on sharply improved operating profitability and a fixed share-issuance cap that limits further dilution. Bulls view the update as supportive of buybacks and potential short covering, while bears point to weaker sales, remaining debt, and uncertainty around the companys strategy; unusual warrant activity has also fueled speculation of an upcoming move.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Anticipated international expansion of ANKTIVA is driving attention, particularly remarks from Dr. Patrick Soon-Shiong about potential UAE and Saudi Arabian access for lymphopenia and additional cancers, alongside completed German labeling and packaging for the European rollout. Traders are broadly bullish on overseas commercialization, while skeptics note that several Middle East expansions remain unconfirmed without formal regulatory announcements and continue to debate revenue timing and FDA risk.

Polygon

Polygons pivot toward regulated stablecoin payments, real-world assets, and enterprise integrations is driving attention, with traders citing network upgrades, rising usage, and reported partnerships with major payment platforms. The community remains divided: bulls view the utility and adoption growth as a long-term catalyst, while skeptics focus on persistent selling, dilution concerns, and POL lagging the broader crypto market.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Upcoming quarterly earnings are the dominant catalyst, with traders positioning for a potentially volatile reaction and debating whether Palo Alto Networks can deliver a beat and raise. Bulls point to resilient cybersecurity demand and AI-driven threats, while bears argue that elevated valuation and lofty expectations leave the stock vulnerable to a sell-the-news move.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Escalating IranStrait of Hormuz tensions and resulting crude-oil volatility are driving attention, with traders focused on potential fuel-cost pressure and broader travel-sector disruption. The community is divided between bearish views that geopolitical risk and higher oil could weigh on margins and bullish investors who see Carnivals demand, deleveraging, buybacks, and dividend as evidence the selloff is an opportunity.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Anticipation of Candels planned BLA submission for CAN-2409 in localized prostate cancer, supported by positive Phase 3 data and upcoming ASTRO and investor presentations, is driving attention. Bullish traders view the setup as a biotech repricing with possible short covering, while skeptics point to the lack of a filed application, potential dilution, profit-taking, and broader biotech volatility.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Grayscales Zcash ETF listing and expected launch are the dominant catalysts, with traders anticipating new institutional demand alongside a sharp technical breakout and short liquidations. The community is broadly bullish on ZECs privacy-focused use case, though some traders warn the move is overextended and could be a pump-and-dump or vulnerable to profit-taking.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Anticipation of a favorable DEA administrative-law recommendation on broader cannabis rescheduling to Schedule III is driving attention, with traders expecting relief from Section 280E taxes and greater institutional access for U.S. operators. Bulls also cite Trulieves medical-focused business and NYSE listing, while skeptics note the recommendation is nonbinding, timing remains uncertain, and recent earnings and price action have been mixed.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Renewed U.S.-Iran hostilities, tanker attacks and disruption around the Strait of Hormuz are driving attention to USO, with traders debating whether constrained flows and depleted reserves outweigh reports of partial shipping corridors. The community is split between bullish supply-shock views and bearish arguments that a Venezuela oil agreement, possible de-escalation and rising inventories could ease crude prices over time.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info